Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study.

about

Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study.

Item

http://www.wikidata.org/entity/Q38692427

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Retrospective evaluation of pr ...... Medical Oncology (ASMO) study.

@en

type

Item

label

Retrospective evaluation of pr ...... Medical Oncology (ASMO) study.

@en

prefLabel

Retrospective evaluation of pr ...... Medical Oncology (ASMO) study.

@en

P1476

Retrospective evaluation of pr ...... Medical Oncology (ASMO) study

@en

P2093

Arife Ulaş

http://www.w3.org/2001/XMLSchema#string

Ayşe Durnalı

http://www.w3.org/2001/XMLSchema#string

Doğan Yazılıtaş

http://www.w3.org/2001/XMLSchema#string

Faysal Dane

http://www.w3.org/2001/XMLSchema#string

Gamze Gököz Doğu

http://www.w3.org/2001/XMLSchema#string

Mahmut Gümüş

http://www.w3.org/2001/XMLSchema#string

Melike Özçelik

http://www.w3.org/2001/XMLSchema#string

Mevlüde İnanç

http://www.w3.org/2001/XMLSchema#string

Necati Alkış

http://www.w3.org/2001/XMLSchema#string

Rashad Rzayev

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group.

Adjuvant ovarian suppression in premenopausal breast cancer.

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.

Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer

New molecular classifications of breast cancer.

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients.

P304

e145-e151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJCO.12685

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Muhammet Ali Kaplan

Ayşe Demirci

P577

2017-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28429422

http://www.w3.org/2001/XMLSchema#string